Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1931 1
1976 1
1996 1
1998 2
2001 2
2002 2
2003 3
2004 2
2005 1
2006 2
2007 1
2009 3
2010 1
2011 1
2012 1
2013 4
2014 3
2015 3
2016 3
2018 2
2019 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension.
Hutchinson PJ, Kolias AG, Timofeev IS, Corteen EA, Czosnyka M, Timothy J, Anderson I, Bulters DO, Belli A, Eynon CA, Wadley J, Mendelow AD, Mitchell PM, Wilson MH, Critchley G, Sahuquillo J, Unterberg A, Servadei F, Teasdale GM, Pickard JD, Menon DK, Murray GD, Kirkpatrick PJ; RESCUEicp Trial Collaborators. Hutchinson PJ, et al. N Engl J Med. 2016 Sep 22;375(12):1119-30. doi: 10.1056/NEJMoa1605215. Epub 2016 Sep 7. N Engl J Med. 2016. PMID: 27602507 Free article. Clinical Trial.
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis.
Borgia SM, Dearden J, Yoshida EM, Shafran SD, Brown A, Ben-Ari Z, Cramp ME, Cooper C, Foxton M, Rodriguez CF, Esteban R, Hyland R, Lu S, Kirby BJ, Meng A, Markova S, Dvory-Sobol H, Osinusi AO, Bruck R, Ampuero J, Ryder SD, Agarwal K, Fox R, Shaw D, Haider S, Willems B, Lurie Y, Calleja JL, Gane EJ. Borgia SM, et al. J Hepatol. 2019 Oct;71(4):660-665. doi: 10.1016/j.jhep.2019.05.028. Epub 2019 Jun 11. J Hepatol. 2019. PMID: 31195062 Free article. Clinical Trial.
BACKGROUND & AIMS: Although off-label use of sofosbuvir-containing regimens occurs regularly in patients with hepatitis C virus (HCV) infection undergoing dialysis for severe renal impairment or end-stage renal disease (ESRD), these regimens are not licensed for this i …
BACKGROUND & AIMS: Although off-label use of sofosbuvir-containing regimens occurs regularly in patients with hepatitis C virus ( …
W. F. DEARDEN, M.R.C.S., L.R.C.P.
[No authors listed] [No authors listed] Br Med J. 1931 Oct 3;2(3691):634-5. Br Med J. 1931. PMID: 20776427 Free PMC article. No abstract available.
Decreased ovarian reserve, dysregulation of mitochondrial biogenesis, and increased lipid peroxidation in female mouse offspring exposed to an obesogenic maternal diet.
Aiken CE, Tarry-Adkins JL, Penfold NC, Dearden L, Ozanne SE. Aiken CE, et al. FASEB J. 2016 Apr;30(4):1548-56. doi: 10.1096/fj.15-280800. Epub 2015 Dec 23. FASEB J. 2016. PMID: 26700734 Free PMC article.
Our observations suggest that lipid peroxidation and mitochondrial biogenesis are the key intracellular pathways involved in programming of ovarian reserve.-Aiken, C. E., Tarry-Adkins, J. L., Penfold, N. C., Dearden, L., Ozanne, S. ...
Our observations suggest that lipid peroxidation and mitochondrial biogenesis are the key intracellular pathways involved in programming of …
Structural determinants of L-type channel activation in segment IIS6 revealed by a retinal disorder.
Hohaus A, Beyl S, Kudrnac M, Berjukow S, Timin EN, Marksteiner R, Maw MA, Hering S. Hohaus A, et al. J Biol Chem. 2005 Nov 18;280(46):38471-7. doi: 10.1074/jbc.M507013200. Epub 2005 Sep 12. J Biol Chem. 2005. PMID: 16157588 Free PMC article.
The importance of a conserved isoleucine residue in the pore-lining segment IIS6 has recently been highlighted by functional analyses of a mutation (I745T) in the Ca(V)1.4 channel causing severe visual impairment (Hemara-Wahanui, A., Berjukow, S., Hope, C. I., Dearden
The importance of a conserved isoleucine residue in the pore-lining segment IIS6 has recently been highlighted by functional analyses of a m …
Prediction of physicochemical properties.
Dearden JC. Dearden JC. Methods Mol Biol. 2012;929:93-138. doi: 10.1007/978-1-62703-050-2_6. Methods Mol Biol. 2012. PMID: 23007428
In silico prediction of drug toxicity.
Dearden JC. Dearden JC. J Comput Aided Mol Des. 2003 Feb-Apr;17(2-4):119-27. doi: 10.1023/a:1025361621494. J Comput Aided Mol Des. 2003. PMID: 13677480 Review.
Simulation-based Assessment to Reliably Identify Key Resident Performance Attributes.
Blum RH, Muret-Wagstaff SL, Boulet JR, Cooper JB, Petrusa ER, Baker KH, Davidyuk G, Dearden JL, Feinstein DM, Jones SB, Kimball WR, Mitchell JD, Nadelberg RL, Wiser SH, Albrecht MA, Anastasi AK, Bose RR, Chang LY, Culley DJ, Fisher LJ, Grover M, Klainer SB, Kveraga R, Martel JP, McKenna SS, Minehart RD, Mitchell JD, Mountjoy JR, Pawlowski JB, Pilon RN, Shook DC, Silver DA, Warfield CA, Zaleski KL; Harvard Assessment of Anesthesia Resident Performance Research Group. Blum RH, et al. Anesthesiology. 2018 Apr;128(4):821-831. doi: 10.1097/ALN.0000000000002091. Anesthesiology. 2018. PMID: 29369062 Free article.
39 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page